Quality. Speed. Results. You shouldn’t have to choose.

API Sourcing

Our strong relationships with world-class manufacturers around the globe reduces supply chain risks and improves your access to high-quality APIs.

API Products

No matter how niche or complex your active pharmaceutical ingredient, LGM Pharma can secure it, import it, and deliver it to your door.

CDMO Services

From concept through commercialization, LGM Pharma’s full-service CDMO will get your product to market faster—no matter your dosage form.

Analytical Services

Protect patient health and your bottom line with a full continuum of analytical method development and stability testing for APIs and drug products.

We care for your API sourcing and CDMO projects as if they were our own

For you, this means:

  • The custom API quantities and chemistries you need, exactly when you need them
  • High-quality therapeutics developed and scaled on time, no matter how niche or complex
  • A continuum of robust support services, including analytical testing and stability studies
  • A tailored regulatory strategy piloted by in-house experts working hand-in-hand with R&D

A successful filing is part science, part art form—and all trust.

Many paths lead from early R&D to FDA-approved cGMP manufacturing, but only one will get you there on your timeline and with the quality you expect. Drawing from decades of experience, we will find that unique path for you, clear it of roadblocks, and tilt it downhill.

From 505(b)(2) projects to ANDAs, controlled substances to HPAPIs, we know what it takes to get to market faster and achieve sustainable success in today’s pharmaceutical market.

Trusted Partnership

Our experienced, science-based team is focused on solving, not selling.

Get to know us

Supply Chain Resilience

We’ve built a vast network of prequalified cGMP manufacturers to keep us agile in uncertain times.

Discover More

Rigorous Quality

We design quality into every process, the key to our spotless compliance record.

Find out How

LGM Pharma launches standalone analytical services for drug developers and manufacturers

Read the Blog

Why Biologics Are a Key Driver of Pharmaceutical Sourcing
Over the last several decades, the global pharmaceutical industry has experienced a significant shift...
Read More >
Overcoming API Challenges for Novel Drug Delivery Systems
The 505(b)(2) regulatory pathway is an increasingly popular method of getting drug approval – and one...
Read More >
LGM Pharma launches standalone analytical services for drug developers and manufacturers
─Analytical Testing and Stability Services Covering Both Drug Substance and Drug Product are Available...
Read More >